Crystal Lake, Illinois, February 18, 2021 — AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results for 2020 and highlighted the resiliency of the Company’s business model throughout the COVID-19 pandemic.
Fourth Quarter 2020 Summary
- Strong fourth quarter performance — reported sales grew 12%; core sales (excluding acquisitions and currency effects) grew 5%
- Double-digit sales growth for Pharma and Food + Beverage segments (reported and core sales) on broad based demand for our innovative solutions
- Acquisitions contributed to Beauty + Home’s reported sales growth while core sales declined modestly — continued strong demand from personal care and home care markets was offset by a marginally improved, though still below prior year, beauty market and lower custom tooling sales
- Reported earnings per share totaled $0.79 (an increase of 8% compared to the prior year)
- Adjusted earnings per share totaled $0.92 (an increase of 8% compared to the prior year when neutralizing currency effects)
- Achieved another quarter of strong cash flow from operations and free cash flow
- Declared quarterly dividend of $0.36 per share
Annual 2020 Summary
- Diversified business drove performance throughout the pandemic with considerable improvement in the second half of the year
- Reported sales growth of 2% with core sales equal to the prior year
- Reported earnings per share of $3.21 (a decrease of 12% compared to the prior year)
- Adjusted earnings per share of $3.64 (a decrease of 9% compared to the prior year when neutralizing currency effects)
- Earnings were negatively impacted by the effects of the global pandemic on the beauty and beverage markets
- Record cash flow from operations of $570 million (an increase of 11% compared to the prior year)
- Record free cash flow of $324 million (an increase of 19% compared to the prior year)
- Achieved our 27th consecutive year of increasing our aggregate annual dividend amount, returning $93 million to shareholders
- Acquired FusionPKG, a leader in high quality, prestige airless and color cosmetics packaging, and conception-to-launch turnkey solutions for the North American beauty market
- Expanded portfolio of digital health offerings through a strategic investment in Sonmol, the acquisition of the assets of Cohero Health, and the launch of a connected inhaler program for respiratory diseases in India with Lupin Limited
- Furthered our ESG commitments and received additional recognition (Newsweek’s Most Responsible Companies, Barron’s Most Sustainable Companies, CDP’s A List and Supplier Engagement leader, ISS ESG Prime Status, EcoVadis Gold)
